Kemnay Advisory Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Kemnay Advisory Services’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,735	Closed	-$988K	–	117
2021 Q1	$988K	Sell	10,735 -360	-3%	-$30.4K	0.14%	44
2020 Q4	$812K	Buy	+11,095	New	+$825K	0.1%	69
2020 Q3	–	Sell	-11,561	Closed	-$643K	–	106
2020 Q2	$643K	Buy	+11,561	New	+$495K	0.1%	40

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Kemnay Advisory Services's HZNP Position: Q2 2021 in Review

Kemnay Advisory Services sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2021, closing a stake of 10,735 shares — an estimated $988K sold.

Kemnay Advisory Services first reported a position in HZNP in Q2 2020 and held it in 3 quarters. The position peaked at $988K in Q1 2021. 526 funds tracked by Wall St. Rank hold HZNP as of Q2 2021.

Kemnay Advisory Services reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2021 after selling out during the quarter.
Kemnay Advisory Services sold 10,735 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2021, an estimated $988K.
Kemnay Advisory Services first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 3 quarters.
Kemnay Advisory Services's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $988K in Q1 2021.
526 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2021.

Based on Kemnay Advisory Services's 13F filing for Q2 2021, filed 16 Aug 2021.